Tiny Arbutus Biopharma Wins Patent Litigation Fight with COVID-19 Vaccine Implications – Motley Fool

Arbutus Biopharma (NASDAQ: ABUS) has for some years owned the rights to a technology that can be used to deliver messenger RNA to a patients cells. Back in January 2019, Moderna (NASDAQ: MRNA), whose … [+1861 chars]